Insider Transactions in Q4 2020 at Summit Therapeutics Inc. (SMMT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,713
-100.0%
|
$54,852
$4.44 P/Share
|
|
Nov 30
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,713
+50.0%
|
$13,713
$1.79 P/Share
|
|
Nov 27
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,569
-100.0%
|
$118,276
$4.39 P/Share
|
|
Nov 27
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,569
+40.23%
|
$29,569
$1.86 P/Share
|
|
Nov 25
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,070
-100.0%
|
$48,280
$4.32 P/Share
|
|
Nov 25
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,070
+50.0%
|
$12,070
$1.92 P/Share
|
|
Nov 24
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,374
-100.0%
|
$45,496
$4.21 P/Share
|
|
Nov 24
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,374
+50.0%
|
$11,374
$1.92 P/Share
|
|
Nov 23
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,987
-100.0%
|
$27,948
$4.4 P/Share
|
|
Nov 23
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,987
+50.0%
|
$6,987
$1.92 P/Share
|
|
Nov 06
2020
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
14,071,856
+20.0%
|
$42,215,568
$3.34 P/Share
|